140 related articles for article (PubMed ID: 22455858)
1. [Mutant K-ras gene in pathogenesis of pancreatic ductal adenocarcinoma].
Guan J; Chen J
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):62-5. PubMed ID: 22455858
[No Abstract] [Full Text] [Related]
2. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
[TBL] [Abstract][Full Text] [Related]
3. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis.
Matsubayashi H; Watanabe H; Ajioka Y; Nishikura K; Yamano M; Seki T; Saito T; Matsubayashi T
Pancreas; 2000 Jul; 21(1):77-85. PubMed ID: 10881936
[TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells.
Agbunag C; Bar-Sagi D
Cancer Res; 2004 Aug; 64(16):5659-63. PubMed ID: 15313904
[TBL] [Abstract][Full Text] [Related]
6. Lack of apoptosis in PanIN-1 and PanIN-2 lesions associated with pancreatic ductal adenocarcinoma is not dependent on K-ras status.
Lüttges J; Neumann S; Jesenofsky R; Borries V; Löhr M; Klöppel G
Pancreas; 2003 Oct; 27(3):e57-62. PubMed ID: 14508142
[TBL] [Abstract][Full Text] [Related]
7. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
8. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
9. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
10. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
12. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer.
Sutaria DS; Jiang J; Azevedo-Pouly AC; Wright L; Bray JA; Fredenburg K; Liu X; Lu J; Torres C; Mancinelli G; Grippo PJ; Coppola V; Schmittgen TD
Sci Rep; 2019 Jul; 9(1):11147. PubMed ID: 31367007
[TBL] [Abstract][Full Text] [Related]
13. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
[TBL] [Abstract][Full Text] [Related]
15. [Mechanistic insights for pancreatic carcinogenesis].
Furukawa T; Horii A
Nihon Rinsho; 2006 Jan; 64 Suppl 1():27-31. PubMed ID: 16457215
[No Abstract] [Full Text] [Related]
16. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
[TBL] [Abstract][Full Text] [Related]
17. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
Dunne RF; Hezel AF
Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
[TBL] [Abstract][Full Text] [Related]
18. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance].
Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210
[TBL] [Abstract][Full Text] [Related]
19. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study.
Crous-Bou M; Porta M; Morales E; López T; Carrato A; Puigdomènech E; Real FX;
Cancer Causes Control; 2009 Jul; 20(5):591-9. PubMed ID: 19083106
[TBL] [Abstract][Full Text] [Related]
20. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
